ARTICLE
19 October 2026

Diagnosis and Treatment Report of Parkinson’s Disease Complicated by Cerebrovascular Disease, Mood Disorder, and Gastrointestinal Dysfunction

Haowen Zhang1*
Show Less
1 Laixi People’s Hospital, Qingdao 266600, Shandong, China
CNR 2026 , 4(3), 92–98; https://doi.org/10.26689/CNR.v4i3.15704
© 2026 by the Author. Licensee: Bio-Byword Scientific Publishing Pty Ltd, Australia. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution 4.0 International License ( https://creativecommons.org/licenses/by/4.0/ )
Abstract

Parkinson’s disease is a degenerative disease of the central nervous system with a high incidence in middle-aged and elderly people. In addition to typical motor impairment, non-motor symptoms can occur throughout the entire disease course, and mood disorders and gastrointestinal autonomic dysfunction are the most common comorbid manifestations. Clinically, Parkinson’s motor symptoms, anxiety and depression, and gastrointestinal somatic symptoms interact with each other, forming a vicious cycle and increasing the difficulty of diagnosis and treatment. This article reports a 63-year-old male patient, Guo Zunbo, who successively underwent cataract intraocular lens implantation in the ophthalmology department of the hospital, visited the gastroenterology outpatient clinic multiple times for gastroesophageal reflux, and was diagnosed in the neurology department with primary Parkinson’s disease, ischemic cerebrovascular disease, and comorbid anxiety and depression. After adding Madopar combined with pramipexole, the overall condition improved. This case suggests that when clinically encountering patients with Parkinson’s disease, attention should not be limited to motor manifestations such as tremor and rigidity; clinicians should also actively identify mood and gastrointestinal autonomic impairment, while taking into account comorbidities in geriatric ophthalmology, break the interaction chain among multisystem symptoms, and improve the overall diagnosis and treatment effect in elderly patients with multiple coexisting diseases.

Keywords
Parkinson’s disease
Autonomic dysfunction
Anxiety and depression
Gastroesophageal reflux
Intraocular lens implantation
References

[1] Chinese Society of Parkinson’s Disease and Movement Disorders, Chinese Medical Association, 2020, Chinese Guidelines for the Treatment of Parkinson’s Disease (4th edition). Chinese Journal of Neurology, 53(12): 973–986.

[2] Chen B, Li SH, 2021, Recognition and Management of Non-motor Symptoms in Parkinson’s Disease. Chinese Journal of Neurology, 54(6): 622–627.

[3] Wang XD, 2017, Diagnosis and Differential Diagnosis of Vascular Parkinsonism. Chinese Journal of Geriatric Heart Brain and Vessel Diseases, 19(5): 449–451.

[4] Zhang Y, Wu ZG, 2022, Clinical Research Progress of Drug-Induced Parkinsonism. Chinese Journal of Pharmacovigilance, 24(3): 289–294.

[5] Liu ZG, Gan J, 2019, Rational Use of Dopamine Receptor agonists in Parkinson’s Disease. Chinese Journal of Nervous and Mental Diseases, 45(8): 497–500.

[6] Yang MH, Li SD, 2023, Expert Consensus on Integrated Traditional Chinese and Western Medicine Intervention for Parkinson’s Disease Complicated with Depression and Anxiety. Chinese Journal of Integrated Traditional and Western Medicine, 43(2): 145–152.

[7] Parkinson’s Disease Rehabilitation Professional Committee of Chinese Association of Rehabilitation Medicine, 2018, Chinese Expert Consensus on Rehabilitation of Parkinson’s Disease. Chinese Journal of Rehabilitation Theory and Practice, 24(7): 745–752.

[8] Chinese Society of Gastroenterology, Chinese Medical Association, 2022, Chinese Guidelines for the Diagnosis and Treatment of Gastroesophageal Reflux Disease (2022, Xi’an). Chinese Journal of Digestion, 42(10): 649–665.

Share
Back to top